Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (301-310 of 386) with videos related to

Pageof 39
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2011
Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'C Blake Gilks, Blaise A Clarke, Guangming Han, et al.
The American Journal of Surgical Pathology|April 27, 2007
p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomasRussell Vang, Allen M Gown, Maryam Farinola, et al.
Cancer|December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsA D Seidman, H I Scher, M H Heinemann, et al.
Archives of Pathology & Laboratory Medicine|December 10, 2019
Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology TraineesMarios A Gavrielides, Meghan Miller, Ian S Hagemann, et al.
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Breast Cancer Research and Treatment|March 17, 2023
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastasesS Chew Minmin, A Bacotti, Y Chen, et al.
Reproductive Biology and Endocrinology : RB&E|July 25, 2018
Elective egg freezing and its underlying socio-demography: a binational analysis with global implicationsM C Inhorn, D Birenbaum-Carmeli, J Birger, et al.
Mucosal Immunology|January 5, 2017
Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibilityK K Smith-McCune, J F Hilton, U Shanmugasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxelDeborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Pageof 39

Showing results (301-310 of 386) with videos related to

Sort By:
Pageof 39
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2011
Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'C Blake Gilks, Blaise A Clarke, Guangming Han, et al.
The American Journal of Surgical Pathology|April 27, 2007
p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomasRussell Vang, Allen M Gown, Maryam Farinola, et al.
Cancer|December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsA D Seidman, H I Scher, M H Heinemann, et al.
Archives of Pathology & Laboratory Medicine|December 10, 2019
Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology TraineesMarios A Gavrielides, Meghan Miller, Ian S Hagemann, et al.
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Breast Cancer Research and Treatment|March 17, 2023
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastasesS Chew Minmin, A Bacotti, Y Chen, et al.
Reproductive Biology and Endocrinology : RB&E|July 25, 2018
Elective egg freezing and its underlying socio-demography: a binational analysis with global implicationsM C Inhorn, D Birenbaum-Carmeli, J Birger, et al.
Mucosal Immunology|January 5, 2017
Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibilityK K Smith-McCune, J F Hilton, U Shanmugasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxelDeborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Pageof 39